TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novo Nordisk A/S
Closing information (x1000 EUR)
| Closing information | 2018/12 | 2017/12 (consolidated) | 2016/12 (consolidated) |
| Turnover |
0
|
15,003,022
|
15,035,511 |
| Financial expenses |
205,913
|
97,654 | |
| Earnings before taxes |
6,376,297
|
6,538,704
|
6,429,302 |
| Total assets |
14,833,478
|
13,748,338
|
13,119,956 |
| Current assets |
7,909,876
|
8,069,954
|
8,039,115 |
| Current liabilities |
7,253,298
|
6,320,568
|
6,380,609 |
| Equity capital |
6,941,948
|
6,691,158
|
6,089,126 |
| - share capital |
65,618
|
67,160
|
68,600 |
| Employees (average) |
1,000
|
42,682
|
42,446 |
Financial ratios
| Fiscal year | 2018/12 | 2017/12 (consolidated) | 2016/12 (consolidated) |
| Solvency |
46.8%
|
48.7%
|
46.4% |
| Turnover per employee |
0
|
352
|
354 |
| Profit as a percentage of turnover |
43.6%
|
42.8% | |
| Return on assets (ROA) |
49.1%
|
49.7% | |
| Current ratio |
109.1%
|
127.7%
|
126.0% |
| Return on equity (ROE) |
91.9%
|
97.7%
|
105.6% |
| Change turnover | |||
| Change turnover % |
0%
|
4% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
1%
|
3% |
Total value of public sale
| Fiscal year | 2018/12 | 2017/12 (consolidated) | 2016/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.